Boothbay Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,270
| Closed | -$335K | – | 1490 |
|
|
2025
Q1 | $335K | Sell |
50,270
-1,860
| -4% | -$12.4K | 0.01% | 861 |
|
|
2024
Q4 | $655K | Buy |
52,130
+8,894
| +21% | +$112K | 0.02% | 657 |
|
|
2024
Q3 | $799K | Hold |
43,236
| – | – | 0.02% | 679 |
|
|
2024
Q2 | $931K | Sell |
43,236
-21,936
| -34% | -$472K | 0.02% | 636 |
|
|
2024
Q1 | $1.76M | Buy |
65,172
+16,891
| +35% | +$455K | 0.03% | 466 |
|
|
2023
Q4 | $1.45M | Sell |
48,281
-83,911
| -63% | -$2.51M | 0.04% | 497 |
|
|
2023
Q3 | $2.71M | Buy |
+132,192
| New | +$2.71M | 0.06% | 321 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 762 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 801 |
|
|
2018
Q2 | – | Sell |
-19,032
| Closed | -$357K | – | 756 |
|
|
2018
Q1 | $357K | Buy |
+19,032
| New | +$357K | 0.04% | 313 |
|
|
2017
Q4 | – | Sell |
-34,933
| Closed | -$249K | – | 719 |
|
|
2017
Q3 | $249K | Buy |
34,933
+16,922
| +94% | +$121K | 0.04% | 359 |
|
|
2017
Q2 | $137K | Sell |
18,011
-6,098
| -25% | -$46.4K | 0.03% | 513 |
|
|
2017
Q1 | $193K | Buy |
+24,109
| New | +$193K | 0.04% | 522 |
|